Candidiasis clinical trials
The registry lists 265 studies for Candidiasis across more than 10 countries. 20 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-23.
Status
- Completed
- 196
- Status unknown
- 25
- Terminated
- 20
- Recruiting
- 13
- Not yet recruiting
- 6
- Withdrawn
- 4
Phase
- Phase 3
- 61
- Phase 2
- 45
- Phase 4
- 29
- Phase 1
- 21
- Early Phase 1
- 2
Where
- United States
- 100
- France
- 25
- Spain
- 20
- Italy
- 17
- China
- 16
- Canada
- 15
Who runs them
Pfizer (22) · Merck Sharp & Dohme LLC (11) · National Institute of Allergy and Infectious Diseases (NIAID) (10) · Scynexis, Inc. (10) · Astellas Pharma Inc (9) · National Cancer Institute (NCI) (7) · Cidara Therapeutics Inc. (4) · University Medical Center Groningen (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 265 — search for more.
- Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant OutcomesRecruitingNCT059086821 country
- Large Algorithm Setting and Validation StudyRecruitingNCT076074701 country
- Oropharyngeal Candidiasis (OPC) and S-ECCRecruitingNCT057611971 country
- Prospective Clinical Study, Using a Medical Device (RepHegyn) as an Adjuvant in the Treatment of Fungal (Candidiasis) and Bacterial InfectionsNot yet recruitingNCT073672951 country
- One-stage Exchange in Candida Periprosthetic Infection a Suitable Way to goRecruitingNCT073031011 country
- PTX3-targeted Antifungal ProphylaxisRecruitingNCT03828773Not applicable3 countries
- Biofilm Formation and Antifungal Resistance in Candida SpeciesNot yet recruitingNCT07245563
- Vaginal Ecosystem and Network in the United States StudyEnrolling by invitationNCT064727652 countries
- Invasive Candidiasis in Critical CareRecruitingNCT064561511 country
- Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell TransplantsRecruitingNCT03717623Phase 41 country
- Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/VulvovaginitisRecruitingNCT06835361Phase 2/32 countries
- Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal CandidiasisRecruitingNCT06480604Not applicable1 country
- Efficacy of the Vacucis Candida® AutovaccineNot yet recruitingNCT05289375Not applicable1 country
- Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal InfectionNot yet recruitingNCT06450990Phase 1/2
- CelAgace™ OraRinse Solution for Treatment of CandidiasisNot yet recruitingNCT03250923Phase 1/21 country
- Epidemiological Study of Vulvovaginal Candidiases Strain Types and Risk Factors Among Gynecological Outpatients in ChinaNot yet recruitingNCT06200389
- ECMM Candida Registry - CandiRegRecruitingNCT034500051 country
- Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy PersonsRecruitingNCT05916729Phase 41 country
- Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical TrialRecruitingNCT03075046Not applicable1 country
- The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis SymptomsRecruitingNCT05367089Phase 31 country
- Efficacy of 5% Nanochitosan Paste in the Treatment of Oral CandidosisCompletedNCT07793331Phase 2
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 39 countries
- Staging Candidiasis in ICU PatientsCompletedNCT013226981 country
- Kinetics of Serum β-D-glucan During Peritonitis With Candida in ResuscitationCompletedNCT03140748Not applicable1 country
- An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida AurisCompletedNCT04148287Phase 21 country
- Fluconazole Versus Micafungin in Neonates With CandidiasisCompletedNCT02145832Phase 2/35 countries
- Pharmacokinetic Study in Healthy Lactating Women Exposed to IbrexafungerpCompletedNCT06954493Phase 11 country
- Study of Lactobacillus in Adjuvant Treatment of RVVCCompletedNCT04699240Phase 41 country
- Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill PatientsCompletedNCT070052581 country
- Analysis of Candida-Associated Osteoarticular Infections: Multicenter Turkish DataCompletedNCT067887821 country
- A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusCompletedNCT05707832Phase 31 country
- Prospective Observational Study on the Incidence of Opportunistic Fungal InfectionsCompletedNCT057071561 country
- Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedNCT00413218Phase 325 countries
- Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal TreatmentCompletedNCT03059992Phase 38 countries
- A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or CandidemiaTerminatedNCT01982071Phase 41 country
- A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical SubjectsCompletedNCT01122368Phase 215 countries
- Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida MeningitisCompletedNCT03421002Phase 21 country
- Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 12 countries
- Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus SppTerminatedNCT02646800Phase 41 country
- The Role of Interferon-gamma in Immune Responses to Invasive CandidiasisCompletedNCT052357111 country
- A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive CandidiasisTerminatedNCT03090334Not applicable1 country
- Non-ablative Er:YAG for Recurrent CandidiasisCompletedNCT06572488Not applicable1 country
- Clinical Study to Evaluate the Efficacy of an Anti-Fungal SupplementCompletedNCT06146504Not applicable1 country
- CAMB/MAT2203 in Patients With Mucocutaneous CandidiasisCompletedNCT02629419Phase 21 country
- Safety and Tolerability Studies of CanProFem-AK, Vaginal Suppositories in Healthy VolunteersCompletedNCT06535126Phase 11 country
- Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal CandidiasisCompletedNCT06120816Phase 11 country
- Ibrexafungerp for the Treatment of Complicated Vulvovaginal CandidiasisCompletedNCT05399641Phase 31 country
- Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)CompletedNCT03363841Phase 34 countries
- Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisCompletedNCT02244606Phase 25 countries
- Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic PatientsWithdrawnNCT00304772Phase 41 country